Seperate state no solution for North Karnataka says Yeddyurappa

Bengaluru, Jul 13:  Karnataka Deputy chief minister Dr CN Ashwath Narayan on Monday urged chief minister BS Yediyurappa to cancel the license of private hospitals and private medical colleges which did not hand over their 50 per cent beds, to the government, Karnataka Deputy Chief Minister's Office said.

On June 26, the Karnataka government reserved about 50 per cent for COVID-19 patients in some private hospitals in Bengaluru.

Earlier in the day, former Karnataka Chief Minister HD Kumaraswamy said that the state government should provide vitamin C drug, Ayush Ministry-certified immunity boosters and sanitisers to every household in the wake of the coronavirus spread.

According to the Union Health Ministry, Karnataka has recorded 38,843 cases of COVID-19 to date.

Mysuru, Jan 22: Former Chief Minister Siddaramaiah here on Wednesday urged the state government to initiate an unbiased investigation into the Mangaluru airport bomb case.

Addressing media persons here, he said, “The incident has created panic among the public and such incidents are being repeated due to the failure of intelligence agencies of the state”.

On accused Aditya Rao, the suspect in the case, who surrendered before Bengaluru police on Wednesday morning, the senior Congress leader said, “I have not yet gathered complete information about the accused in the case, therefore I would not like to comment about him.”

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.